What is SpaDerma?
SpaDerma operates as a leading medical spa with multiple locations across Chicago and the North Shore, offering a comprehensive suite of advanced skincare, cosmetic injectables, and laser therapy treatments. Their service portfolio includes popular procedures such as Hydrafacial, SkinPen, and Moxi, alongside treatments for acne, aging, and hydration. The company has established a reputation for performing a high volume of procedures, reflecting its deep market penetration and client trust. SpaDerma's business model focuses on providing effective, results-driven solutions for a diverse clientele seeking aesthetic enhancements and dermatological care.
How much funding has SpaDerma raised?
SpaDerma has raised a total of $780K across 2 funding rounds:
Debt
$350K
Debt
$430K
Debt (2020): $350K with participation from PPP
Debt (2021): $430K led by PPP
What's next for SpaDerma?
The substantial enterprise-level funding and recent strategic investment position SpaDerma for accelerated growth and market expansion. This capital infusion is likely to fuel initiatives such as opening new locations, enhancing service offerings with cutting-edge technologies, and potentially expanding into new geographic markets. Strategic investments of this magnitude often signal a move towards scaling operations, optimizing customer acquisition strategies, and solidifying market leadership. SpaDerma is poised to leverage this financial backing to further innovate within the medical spa industry and enhance its competitive advantage.
See full SpaDerma company page
